| Date Filed | Type | Description |
| 02/11/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 11/03/2021 |
4
| Foresite Capital Management III, LLC (10% Owner) has filed a Form 4 on Aclaris Therapeutics, Inc.|
Txns:
| Disposed of 1,954,904 shares
@ $0
Acquired 8,276 shares
@ $0 |
|
| 02/16/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/11/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/10/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 03/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/13/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/13/2020 |
SC 13G/A
| Foresite Capital Fund III, L.P. reports a 0.8% stake in Replimune Group, Inc. |
| 11/05/2019 |
3/A
| Foresite Capital Management II, LLC (10% Owner) has filed a Form 3/A on AERIE PHARMACEUTICALS INC |
| 09/06/2019 |
4
| Foresite Capital Management II, LLC (10% Owner) has filed a Form 4 on AERIE PHARMACEUTICALS INC|
Txns:
| Bought 9,300 shares
@ $18.48, valued at
$171.9k
Bought 90,900 shares
@ $18.48, valued at
$1.7M
Bought 15,700 shares
@ $18.42, valued at
$289.2k
|
|
| 09/04/2019 |
4
| Foresite Capital Management II, LLC (10% Owner) has filed a Form 4 on AERIE PHARMACEUTICALS INC|
Txns:
| Bought 25,000 shares
@ $21.36, valued at
$534k
Bought 34,900 shares
@ $20.54, valued at
$716.8k
Bought 15,100 shares
@ $21.45, valued at
$323.9k
|
|
| 08/23/2019 |
4
| Foresite Capital Management II, LLC (10% Owner) has filed a Form 4 on AERIE PHARMACEUTICALS INC|
Txns:
| Bought 1,153 shares
@ $23.25, valued at
$26.8k
Bought 6,700 shares
@ $23.68, valued at
$158.7k
Bought 38,300 shares
@ $23.42, valued at
$897k
|
|
| 08/20/2019 |
4
| Foresite Capital Management II, LLC (10% Owner) has filed a Form 4 on AERIE PHARMACEUTICALS INC|
Txns:
| Bought 100,000 shares
@ $24.23, valued at
$2.4M
Bought 3,847 shares
@ $23.34, valued at
$89.8k
Bought 50,000 shares
@ $23.21, valued at
$1.2M
|
|
| 08/14/2019 |
4
| Foresite Capital Management II, LLC (10% Owner) has filed a Form 4 on AERIE PHARMACEUTICALS INC|
Txns:
| Bought 189,555 shares
@ $24.43, valued at
$4.6M
Bought 71,097 shares
@ $24.92, valued at
$1.8M
Bought 178,903 shares
@ $25.52, valued at
$4.6M
Bought 100,000 shares
@ $23.73, valued at
$2.4M
|
|
| 08/14/2019 |
3
| Foresite Capital Management II, LLC (10% Owner) has filed a Form 3 on AERIE PHARMACEUTICALS INC |
| 02/13/2019 |
SC 13G/A
| Foresite Capital Fund III, L.P. reports a 6.2% stake in Achaogen, Inc. |
| 02/13/2019 |
SC 13G/A
| Foresite Capital Fund III, L.P. reports a 7.1% stake in CymaBay Therapeutics, Inc. |
| 02/13/2019 |
SC 13G/A
| Foresite Capital Fund III, L.P. reports a 4.6% stake in Arcus Biosciences, Inc. |
| 01/23/2019 |
SC 13G
| Foresite Capital Fund III, L.P. reports a 6.4% stake in Replimune Group, Inc. |
| 03/23/2018 |
SC 13G
| Foresite Capital Fund III, L.P. reports a 9.6% stake in Arcus Biosciences, Inc. |
| 02/13/2018 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/13/2018 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/13/2018 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 11/06/2017 |
SC 13G
| Foresite Capital Fund III, L.P. reports a 6.2% stake in CymaBay Therapeutics, Inc. |
| 05/31/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/31/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
| 05/05/2017 |
SC 13G
| Foresite Capital Fund III, L.P. reports a 5% stake in Verona Pharma plc |
| 04/24/2017 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/13/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend] |
| 02/13/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend] |
| 12/21/2016 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals |
| 11/04/2016 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals |
| 10/11/2016 |
4/A
| Foresite Capital Management II, LLC (10% Owner) has filed a Form 4 on AERIE PHARMACEUTICALS INC|
Txns:
| Sold 24,813 shares
@ $40.3399, valued at
$1M
Sold 25,187 shares
@ $40.3399, valued at
$1M
|
|
| 10/07/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|